THE METABOLIC EFFECTS OF STEROID HORMONES IN OSTEOPOROSIS

^{Medical Service of the Massachusetts General Hospital and the Department of Medicine of the Harvard Medical School, Boston}

The expense of these studies was defrayed by grants from the Josiah Macy, Jr. Foundation, from the Rockefeller Foundation, and from the National Research Council (Committee for Research in the Problems of Sex). A bed supported by the Mallinckrodt Chemical Company on the Metabolic Ward was used for part of these studies.

Presented in part at the twenty-sixth annual meeting of the Association for the Study of Internal Secretions, Atlantic City, New Jersey, June 8, 1942, in connection with a symposium on “Relation of Endocrines to Skeletal Development”; an outline of this presentation may be found in: Reifenstein, E. C., Jr.; Albright, F.; Parson, W.; and Bloomberg, E.: The effect of estradiol benzoate and of testosterone propionate and of combinations of both on post-menopausal osteoporosis and senile osteoporosis, Endocrinology, 30: S1024 (1942). Also presented in part at the first annual meeting of the American Federation for Clinical Research, Minneapolis, Minn., April 20, 1942. Preliminary reports of part of these data may be found in: Albright, F.; Reifenstein, E. C., Jr.; and Forbes, A. P.: Conferences on the Metabolic Aspects of Convalescence (Including Bone and Wound Healing), Transactions of the First Meeting, Sept. 11-12, 1942, pages 5-7, 37-38; Transactions of the Second Meeting, December 11-12, 1942, pages 69, 96-98; Transactions of the Third Meeting, March 12-13, 1943, pages 63-65; and Transactions of the Fourth Meeting, June 11-12, 1943, pages 77-85. Transactions distributed by the Josiah Macy, Jr. Foundation, New York, N. Y.

The work described in this paper was done in part under a contract, recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and the Massachusetts General Hospital.

Find articles by Reifenstein, E. in: JCI | PubMed | Google Scholar

^{Medical Service of the Massachusetts General Hospital and the Department of Medicine of the Harvard Medical School, Boston}

The expense of these studies was defrayed by grants from the Josiah Macy, Jr. Foundation, from the Rockefeller Foundation, and from the National Research Council (Committee for Research in the Problems of Sex). A bed supported by the Mallinckrodt Chemical Company on the Metabolic Ward was used for part of these studies.

Presented in part at the twenty-sixth annual meeting of the Association for the Study of Internal Secretions, Atlantic City, New Jersey, June 8, 1942, in connection with a symposium on “Relation of Endocrines to Skeletal Development”; an outline of this presentation may be found in: Reifenstein, E. C., Jr.; Albright, F.; Parson, W.; and Bloomberg, E.: The effect of estradiol benzoate and of testosterone propionate and of combinations of both on post-menopausal osteoporosis and senile osteoporosis, Endocrinology, 30: S1024 (1942). Also presented in part at the first annual meeting of the American Federation for Clinical Research, Minneapolis, Minn., April 20, 1942. Preliminary reports of part of these data may be found in: Albright, F.; Reifenstein, E. C., Jr.; and Forbes, A. P.: Conferences on the Metabolic Aspects of Convalescence (Including Bone and Wound Healing), Transactions of the First Meeting, Sept. 11-12, 1942, pages 5-7, 37-38; Transactions of the Second Meeting, December 11-12, 1942, pages 69, 96-98; Transactions of the Third Meeting, March 12-13, 1943, pages 63-65; and Transactions of the Fourth Meeting, June 11-12, 1943, pages 77-85. Transactions distributed by the Josiah Macy, Jr. Foundation, New York, N. Y.

The work described in this paper was done in part under a contract, recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and the Massachusetts General Hospital.

Find articles by Albright, F. in: JCI | PubMed | Google Scholar